ADHD & Perimenopause
The invisible mental load
When Two Worlds Collide
If you live with ADHD and are in your late thirties, forties, or early fifties, you may have noticed something unsettling: your brain feels different. Tasks that used to be manageable now feel overwhelming. You are more forgetful, more emotionally reactive, and more exhausted, even when your life circumstances have not fundamentally changed.
You may have wondered whether your ADHD is worsening, whether you are developing early cognitive decline, or whether stress is simply catching up with you. For many women, the answer is none of the above. What is happening is the intersection of two neurobiological realities: ADHD and perimenopause.
This post explores what we know from research about how these two conditions interact, why symptoms can intensify during this life stage, and what tends to help.
Important note:
This blog is for general psychoeducation only. If you are experiencing significant changes in mood, cognition, or daily functioning, please speak with your GP or a registered psychologist.
Understanding what is happening — and why it matters
1. What is ADHD?
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that affects how the brain manages attention, impulse control, and executive functions.
Core areas of difficulty:
● Sustaining focus, especially on low-stimulation tasks
● Planning, organising, and managing time
● Regulating emotions and tolerating frustration
● Working memory (holding information in mind while doing something else)
● Managing mental "noise" and many ideas or thoughts at once
These difficulties are related to differences in dopamine and noradrenaline which are brain chemicals that support motivation, attention, and self-regulation.
2. What is Perimenopause?
Perimenopause is the transitional phase leading up to menopause. It typically begins in a woman's mid-to-late 40s (though it can start earlier) and can last several years. During this time, the ovaries gradually produce less oestrogen, causing hormonal fluctuations rather than a smooth decline.
Oestrogen affects many systems in your body, including:
Body & Energy
● Body temperature regulation
● Energy levels and motivation
● Anxiety and stress response
● Cognitive processing speed
Brain & Mood
● Brain function, memory, and concentration
● Mood stability and emotional regulation
● Sleep quality and circadian rhythm
● Dopamine and serotonin activity
3. Why ADHD + Perimenopause Interact
Oestrogen actively supports dopamine function in the brain. This is the same dopamine system that is affected in ADHD. As oestrogen levels become more unpredictable during perimenopause:
● Dopamine regulation becomes less stable
● Executive functioning such as planning, focus, and organisation can deteriorate
● Emotional regulation may become more effortful
● Sleep disruptions can further impair concentration and mood the next day
The result is a compounding effect
“Each condition amplifies the other. Hormonal fluctuations can make ADHD symptoms appear to worsen, not because the ADHD has changed, but because the brain has less hormonal support for regulation.”
4. What is Normal for This Phase?
Many women report significant changes during perimenopause, especially those with ADHD. If any of the following sound familiar, you are not imagining it and you are not alone.
Mood & Sleep Changes
● Waking during the night or difficulty falling asleep
● Greater emotional sensitivity or reactivity
● Increased anxiety or low mood
● Reduced tolerance for stress or uncertainty
● Feeling like "something is wrong with me"
Cognitive & Focus Changes
● "My brain feels busier than ever"
● Difficulty switching off in the evenings
● Increased forgetfulness or losing track mid-sentence
● Starting many things but finishing few
● Feeling overwhelmed by tasks that used to feel manageable
A note on self-compassion
This is a neurobiological and hormonal interaction. Your brain is managing high levels of input with reduced hormonal support. That is genuinely hard.
5. Sleep: Why It Can Be Particularly Affected
Sleeplessness, ADHD and Perimenopause
Sleep is one of the most commonly disrupted areas for women with ADHD during perimenopause, because both conditions independently affect sleep and together, their impact compounds.
Perimenopause-Related Sleep Disruption
● Hot flushes or night sweats interrupting sleep
● Hormonal shifts affecting sleep depth and cycles
● Increased light sleep and reduced restorative sleep
● Early morning waking
ADHD-Related Sleep Disruption
● Racing or busy thoughts at bedtime
● Difficulty disengaging from the day
● Delayed sleep onset (hard to wind down)
● Night waking due to rumination
Sleep disruption affects concentration, mood, impulse control, and emotional regulation the following day, creating a cycle that can make ADHD symptoms feel much worse.
6. What Tends to Help
Rather than pushing harder or expecting the same output as before, the following approaches work with your brain rather than against it:
Externalise the mental load
Externalise the mental load with ADHD and Perimenopause
● Write things down such as notes, lists, reminders, rather than holding them in working memory
● Use visual planners, phone alerts, or structured routines to reduce cognitive effort
● Break large tasks into small, named steps with defined starting points
Create clear transitions
● Build a consistent wind-down sequence in the evening (e.g., dim lights, no screens, same order of tasks)
● Allow buffer time between activities. ADHD brains resist abrupt transitions
Support sleep specifically
● Low-stimulation audio (podcasts, sleep stories, white noise) can help with "busy mind" at bedtime
● Consistent sleep and wake times help stabilise the circadian rhythm
● Keep the bedroom cool to manage temperature fluctuations
Be realistic about capacity
● Energy, focus, and emotional bandwidth may fluctuate across your cycle and week. This is not inconsistency, it is biology
● Prioritise two or three important tasks per day rather than a long to-do list
7. When to Consider Additional Support
It is worth discussing further options with your psychologist or GP if:
● Sleep has been persistently disrupted for more than a few weeks
● You are feeling persistently overwhelmed, low, or anxious
● Daily functioning (work, relationships, home) is significantly affected
● You are questioning whether your current medication (if any) is still working as well as before
Support options may include:
Psychological strategies (e.g., CBT, ADHD-informed therapy, ACT-based approaches)
Medication review with your GP or psychiatrist (ADHD medication dose may need adjustment)
Hormonal support such as Hormone Replacement Therapy (HRT) may reduce the oestrogen fluctuations that amplify ADHD symptoms; discuss with your GP or a menopause specialist
Key Takeaway
“ADHD and perimenopause can amplify each other, but this phase is temporary and manageable. Understanding what is happening in your brain and body is the first step toward finding strategies that actually help.”
Ready to take the next step?
If you would like professional support. Book a consultation with Ashcliffe Psychology or learn more about our counselling services in West Perth.
→ Book online: halaxy.com/profile/ashcliffe-psychology
→ Phone: 1800 468 001
→ Email: info@ashcliffe.com.au
Further Reading & Authoritative Resources
Australasian Menopause Society: www.menopause.org.au
CHADD (Children and Adults with ADHD): chadd.org
ADHD Australia: www.adhdaustralia.org.au
Jean Hailes for Women's Health: www.jeanhailes.org.au
-
The following peer-reviewed and authoritative sources informed this article:
[1] Harlow, S. D., Gass, M., Hall, J. E., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4), 387–395. https://doi.org/10.1097/gme.0b013e31824d8f40
[2] Prior, J. C. (2011). Progesterone for the prevention and treatment of osteoporosis in women. Climacteric, 21(4), 366–374.https://doi.org/10.1080/13697137.2018.1467400
[3] Weber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. Journal of Steroid Biochemistry and Molecular Biology, 142, 90–98. https://doi.org/10.1016/j.jsbmb.2013.06.001
[4] Faraone, S. V., Asherson, P., Banaschewski, T., et al. (2015). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 1, 15020. https://doi.org/10.1038/nrdp.2015.20
[5] Quinn, P. O. (2005). Treating adolescent girls and women with ADHD: Gender-specific issues. Journal of Clinical Psychology, 61(5), 579–587. https://doi.org/10.1002/jclp.20121
[6] Nadeau, K. G., & Quinn, P. O. (2002). Understanding Women with ADHD. Advantage Books.
[7] Shanmugan, S., & Epperson, C. N. (2014). Estrogen and the prefrontal cortex: Towards a new understanding of estrogen's effects on executive functions. Neuroscience & Biobehavioral Reviews, 46, 423–430. https://doi.org/10.1016/j.neubiorev.2014.08.001
[8] McEwen, B. S. (2002). Estrogen actions throughout the brain. Recent Progress in Hormone Research, 57, 357–384.https://doi.org/10.1210/rp.57.1.357
[9] Quinn, P. O., & Madhoo, M. (2014). A review of attention-deficit/hyperactivity disorder in women and girls: Uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders, 16(3). https://doi.org/10.4088/PCC.13r01596
[10] Epperson, C. N., Shanmugan, S., Kim, D. R., et al. (2015). New onset executive function difficulties at menopause: A possible role for lisdexamfetamine. Psychopharmacology, 232(16), 3091–3100. https://doi.org/10.1007/s00213-015-3957-5
[11] Keenan, P. A., Ezzat, W. H., Ginsburg, K., & Moore, G. J. (2001). Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology, 26(6), 577–590. https://doi.org/10.1016/s0306-4530(01)00013-0
[12] Brinton, R. D. (2009). Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's disease. Advances in Drug Delivery Reviews, 61(7–8), 618–629. https://doi.org/10.1016/j.addr.2009.11.007
[13] Baker, F. C., de Zambotti, M., Colrain, I. M., & Bei, B. (2018). Sleep problems during the menopausal transition: Prevalence, impact, and management challenges. Nature and Science of Sleep, 10, 73–95. https://doi.org/10.2147/NSS.S125807
[14] Genazzani, A. R., Pluchino, N., Begliuomini, S., et al. (2007). Neuroactive steroids and the central nervous system in the menopause transition. Gynecological Endocrinology, 23(Suppl 1), 2–10. https://doi.org/10.1080/09513590701584930
[15] Soares, C. N. (2014). Depression and menopause: Current knowledge and clinical recommendations for a critical window. Psychiatric Clinics of North America, 40(2), 239–254. https://doi.org/10.1016/j.psc.2017.01.007
[16] Ramsay, J. R. (2020). Rethinking Adult ADHD: Helping Clients Turn Intentions into Actions. American Psychological Association.
[17] Young, S., & Bramham, J. (2012). Cognitive-Behavioural Therapy for ADHD in Adolescents and Adults: A Psychological Guide to Practice (2nd ed.). Wiley-Blackwell.
DISCLAIMER: The information provided in these blog posts is intended for general educational and informational purposes only. It is not a substitute for professional psychological assessment, diagnosis, or treatment. Individuals should not rely upon this content as professional advice, nor should it be used to guide or replace clinical decision-making.
Although all content is written by qualified mental-health professionals and draws upon contemporary psychological research and recognised frameworks (e.g., APS Code of Ethics, 2014; AHPRA Guidelines for Advertising Regulated Health Services, 2020), the material may not apply to every person or circumstance. Psychological needs are highly individual, and effective care requires a personalised clinical assessment. Reading these posts does not create a therapeutic relationship with Ashcliffe Psychology or any of its clinicians. In an emergency, call 000 or attend your nearest emergency department. If you are experiencing distress, concerned about your mental health, or require support, please contact a registered health professional. Ashcliffe Psychology makes no warranty regarding the accuracy, completeness, or applicability of the content at any point in time. Blog posts may refer to sensitive topics and may be updated or removed as needed to ensure compliance with professional and regulatory standards.
Use of Artificial Intelligence: Ashcliffe Psychology may utilise artificial intelligence (AI) tools in limited circumstances to support content development. Any material generated or informed by AI undergoes review by qualified clinicians to ensure accuracy, legitimacy, and alignment with professional, ethical, and regulatory requirements before publication.
